SCHEMBL26698259

SCHEMBL26698259

COc1cccc(C(=O)C2CCCCN2C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM2B Q8NHM5 4/20 0.57
ALDH1A1 P00352 4/20 0.54
TSHR P16473 1/20 0.54
CHRNA1 P02708 1/20 0.52
CHRNG P07510 1/20 0.52
CHRNB1 P11230 1/20 0.52
CHRNB2 P17787 1/20 0.52
SLC6A2 P23975 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA4 P43681 1/20 0.52
SLC6A3 Q01959 1/20 0.52
CHRND Q07001 1/20 0.52
NPC1 O15118 2/20 0.51
LMNA P02545 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
QSOX1 O00391 1/20 0.51
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776118 0.86 KDM2B (0.51) KDM2BALDH1A1TSHRCHRNA1CHRNG
SCHEMBL27265700 0.81 CNR2 (0.48) ALDH1A1CHRNB2CHRNA4
SCHEMBL25980654 0.81 CNR2 (0.48) ALDH1A1CHRNB2CHRNA4
SCHEMBL18360283 0.81 KDM2B (0.62) KDM2BALDH1A1NPC1LMNARAB9A
SCHEMBL8222788 0.81 USP30 (0.53) KDM2BALDH1A1TSHRCHRNA1CHRNG
SCHEMBL25980703 0.80 CNR2 (0.47) ALDH1A1CHRNB2CHRNA4KMT2AGAA
SCHEMBL5210032 0.79 MGLL (0.62) KDM2BALDH1A1CES2CES1MEN1
SCHEMBL30771226 0.79 MGLL (0.62) KDM2BALDH1A1CES2CES1MEN1
SCHEMBL14646983 0.78 KDM2B (0.57) KDM2BALDH1A1CHRNA1CHRNGCHRNB1
SCHEMBL7309424 0.78 CES2 (0.65) KDM2BNPC1RAB9ASMN1; SMN2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023226965-A1 ROCK INHIBITORS AND USES THEREOF DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2023-11-30 WO disclosed